Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1 Safety And Pharmacokinetic Study Of SU011248 And Capecitabine In Patients With Advanced Solid Tumors

NCT00618124 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00618124
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00618124 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1 Safety And Pharmacokinetic Study Of SU011248 And Capecitabine In Patients With Advanced Solid Tumors
Lead sponsor
Pfizer
Phase
Phase 1
Overall status
Completed
Start date
May 31, 2005
Completion date
July 31, 2008
Enrollment
77 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, neoplasms, solid tumors